Alladapt Immunotherapeutics

North America Legal Chronicle. June 28, 2022

Alladapt Immunotherapeutics’ $100+ Million Financing Round

By Martina Bellini

Goodwin Procter advised Alladapt Immunotherapeutics Inc. on the deal. Alladapt Immunotherapeutics Inc. announced its $100+ million financing round led by Enavate Sciences, a portfolio company created by...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Charlton Aria Acquisition Corp.’s $75 Million Initial Public Offering

Oportun’s $235 Million Debt Refinancing

Aris Mining’s US$450 Million Senior Notes Offering

Reddy Ice’s Acquisition of Aguafría

‘Mercado Crédito XXVII’ Financial Trusts’ Issuance

Crescera Capital’s Acquisition of Segware

Airbus Defence and Space’s Lease Agreement For Three UHF TACSAT Satellite Channels

Belden’s Acquisition Of Voleatech GmbH

Kinetico Health’s Acquisition Of Good Health Centre And The Waldegrave Clinic

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

ADNH Catering’s US$235 Million Initial Public Offering

Sembcorp Industries’ Notes Issuance

Suven Pharmaceuticals’ Merger with Casper Pharma

HomeLane’s Acquisition of DesignCafe

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

Alladapt Immunotherapeutics’ $100+ Million Financing Round

Standard 1 Year Membership Required